CoreValve becomes first transcatheter heart valve approved for valve-in-valve procedures. Chris Newmarker Rendering of the CoreValve right after its transcatheter deployment. (Image courtesy of Medtronic) FDA has cleared the way for ...
Tags: FDA, Medicine, Medical Device
This year is proving to be a pretty good year for many medtech companies. The majority of the largest 40 have seen their stock prices rise by double-digit percentages in 2014, according to a Qmed analysis. Meanwhile, only eight have seen ...
Tags: Medtech Companies, Medical device
Edwards' Sapien XT transcatheter aortic heart valve (Courtesy Edwards Lifesciences) Edwards Lifesciences Corp. (Irvine, CA) has announced both the FDA approval and the U.S. launch of its next-generation Sapien XT transcatheter aortic ...
Tags: Health, Medicine, heart valve
Medtronic's CoreValve transcatheter aortic valve replacement device. (Courtesy Medtronic) Almost before the judge's signature was dry on Friday's federal district court preliminary injunction in favor of Edwards Lifesciences Corp. ...
Edwards Lifesciences has received regulatory approval to sell its third-generation Sapien 3 transcatheter aortic heart valve in Europe. Edwards Lifescience's Sapien 3 could be used in a broader range of patients than earlier TAVR ...
Tags: Sapien, Medtronic', CoreValve
The Gagnon Cardiovascular Institute at Morristown Medical Center became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to ...
Medtronic, a medical device company, has obtained the US Food and Drug Administration (FDA) approval for its CoreValve self-expanding transcatheter system. The device is designed for severe aortic stenosis patients who are too ill or ...
Tags: medical device, Medtronic
Medtronic willfully infringed on an Edwards Lifesciences’ patent with its CoreValve transcatheter heart valve, and owes Edwards nearly $394 million in damages and patent royalties, a federal jury in Delaware found Wednesday. Edwards ...
Tags: Medtronic, CoreValve, transcatheter heart valve, Edwards
Posted in Cardiovascular by Qmed Staff on November 19, 2013 The Sapien 3 could be used in a broader range of patients than earlier TAVR products introduced internationally. Edwards Lifesciences (Irvine, CA) is in the news after The ...
In August, Medtronic was forced to remove its CoreValve percutaneuous heart valves from the market in Germany in light of a ruling that found that the device infringed on patents held by Edwards Lifesciences. A German appeals court, ...
Medtronic, a US-based medical technology company, has announced that a German court has ordered the discontinuation, in its entirety, of a prior court ruling that prohibited the company from commercially marketing or selling the CoreValve ...
Tags: Medtronic, Corevalve System
US-based Medtronic has announced the first implantations of its CoreValve Evolut R recapturable system as part of a clinical study. CoreValve Evolut R recapturable system has CoreValve Evolut R transcatheter valve and EnVeo R recapturable ...
Edwards Lifesciences announced that the injunction imposed by the District Court of Mannheim, Germany against the sales of Medtronic's transcatheter heart valves has become effective. In July 2013, the court ruled that Medtronic's ...
Tags: Heart Valves, Medicine
A court in Germany has found that Medtronic has infringed on Edwards Lifesciences' Spenser patent for transcatheter heart valve technology and granted an injunction banning the sale of CoreValve and CoreValve Evolut systems in the country. ...
Medtronic has treated the first US patient in a global, multicenter clinical trial, designed to compare the accuracy of its CoreValve system with surgical aortic valve replacement in treating patients with severe aortic stenosis and who are ...